|Basis of Allotment|
(This is only an advertisement for information purposes not for publication or distribution, directly or indirectly outside India, and not a prospectus announcement)
Claris Lifesciences Limited
Our Company was originally incorporated as Oracle Laboratories Limited on July 19, 1994 under the Companies Act, 1956, as a public limited company. For more details on the changes in the name and registered office of our Company, please see the chapter on "History and Certain Corporate Matters" on page 145 of the Prospectus. . Registered and Corporate Office: Claris Corporate Headquarters, Near Parimal Railway Crossing, Ellisbridge, Ahmedabad - 380 006. Tel: +91 79 26563331; Fax: +91 79 26565879; Website: www.clarislifesciences.com; Email: email@example.com
Promoters of the Company: Mr. Arjun S. Handa and Sarjan
Financial Private Limited
BASIS OF ALLOTMENT
PUBLIC ISSUE OF 12,632,477 EQUITY SHARES OF FACE VALUE OF RS. 10 EACH (THE "EQUITY SHARES") OF CLARIS LIFESCIENCES LIMITED (THE "COMPANY" OR THE "ISSUER") FOR CASH AT A PRICE OF RS. 228 PER EQUITY SHARE (INCLUDING A SHARE PREMIUM OF RS. 218) TO ALL INVESTORS OTHER THAN ANCHOR INVESTORS AND AT A PRICE OF RS. 293 (INCLUDING A SHARE PREMIUM OF RS. 283) PER EQUITY SHARE TO ANCHOR INVESTORS, AMOUNTING TO RS. 2,460 MILLION IN RELATION TO ALL INVESTORS OTHER THAN ANCHOR INVESTORS AND AMOUNTING TO RS. 540 MILLION IN RELATION TO ANCHOR INVESTORS, AGGREGATING UP TO RS. 3,000 MILLION (THE "ISSUE"). THE ISSUE WILL CONSTITUTE 19.79% OF THE POST-ISSUE PAID UP SHARE CAPITAL OF THE COMPANY.
THE FACE VALUE OF OUR EQUITY SHARES IS RS. 10 EACH AND THE ISSUE PRICE IS 22.8 TIMES THE FACE VALUE. ISSUE OPENED ON NOVEMBER 24, 2010 AND CLOSED ON DECEMBER 02, 2010*
The Bid/Issue progamme was scheduled to close on November 26, 2010, however, the Bid/Issue Period was extended by four working days(i.e.closed on Thursday, December 2,2010).
The Equity Shares of the Company are proposed to be listed on the Bombay Stock Exchange Limited ("BSE") and the trading Is expected to commence on December 20, 2010.
The Company has undertaken the Issue in accordance with the first proviso to Rule 19(2)(b)(ii) of the Securities Contracts (Regulations) Rules, 1957 (the "SCRR"). This being an Issue for less than 25%, but not less than 10%, of the post-Issue capital, the Issue is being made through the 100% Book Building Process wherein at least 60% of the Issue shall be allocated to Qualified Institutional Buyers fQIBs") on a proportionate basis, out of which 5% shall be available for Allotment on a proportionate basis to Mutual Funds only. Our Company has allotted up to 30% of the QIB Portion to the Anchor Investors on a discretionary basis. The remaining QIB portion shall be available for Allotment on a proportionate basis to QIBs including Mutual Funds, subject to valid Bids being received from them at or above the Issue Price. If at least 60% of the Issue cannot be allocated to QIBs, then the entire application money will be refunded forthwith. Further, not less than 10% of the Issue shall be available for Allotment on a proportionate basis to Non-Institutional Bidders and not less than 30% of the Issue shall be available for Allotment on a proportionate basis to Retail Individual Bidders, subject to valid bids being received at or above the Issue Price.
The Company has allotted 1,843,003 Equity Shares to Anchor Investors at Rs. 293 per Equity Share in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009, as amended ("SEBIICDR Regulations"). The Issue received 33,068 applications for 16,256,306 equity shares resulting in 1.2869 times subscription. The details of the applications received in the Issue from Retail Individual Bidders, Non-Institutional Bidders, QIB Bidders and the Anchor Investors categories are as under (Before Technical Rejections) (Including ASBA Applications):
A summary of the final demand at different Bid prices is as under:
The Basis of Allotment was finalized in consultation with the BSE on December 15, 2010.
A. Allotment to Retail Individual Investors (After Technical Rejections) (Including ASBA Applications)
The Basis of Allotment to the Retail Individual Investors, who have bid at Cut-Off Price or above the Issue Price of Rs. 228 per Equity Share, was finalized in consultation with BSE. This category has been subscribed to the extent of 1.2123 times. The total number of Equity Shares allotted in Retail Individual Investor category is 3,789,743 Equity Shares to 30,479 successful applicants. The category-wise details of the Basis of Allotment are (sample) as under
B. Allotment to Non Institutional Investors (After Technical Rejections) (IncludingASBA Applications)
The Basis of Allotment to the Non-Institutional Investors, who have bid at or above the Issue Price of Rs. 228 per Equity Share, was finalized in consultation with BSE. This category has been subscribed to the extent of 1.3912 times The total number of Equity Shares allotted in this category Is 1,263,247 Equity Shares to 61 successful applicants. The category-wise details of the Basis of Allotment are (sample) as under:
C. Allotment to QIBs (After Technical Rejections) (Including ASBA Applications)
Allotment to QIBs has been done on a proportionate basis in consultation with BSE. As per the SEBIICDR Regulations, Mutual Funds were initially allotted 5% of the quantum of shares available (286,824 Equity Shares) and other QIBs were allotted the remaining available shares (5,449,660 Equity Shares) on proportionate basis. The total number of Equity Shares allotted to QIBs is 5,736,484 which were allotted to 17 successful applicants.
D. Allotment to Anchor Investors
Allotment to Anchor Investors has been done in consultation with BRLMs. 1,843,003 Equity Shares were allotted to 4 successful applicants.
The IPO Committee of the Board of Directors of the Company at its meeting held on December 16,2010 has taken on record the Basis of Allotment of the Issue approved by the Designated Stock Exchange viz., BSE and has alloted the Equity Shares to various successful! applicants.
The Confirmation of Allotment Notice cum-Refund Order and allotment advice and notices have been dispatched to the address of the Bidders as registered with the depositories on December 16,2010. Further, the instructions to SCSBs have been dispatched on December 16,2010. In case the same is not received within ten business days, investors may contact at the address given below. The Refund Orders have been over-printed with the Bank Account details as registered, if any, with the depositories. The Equity shares allotted to successful Bidders are being credited to their beneficiary accounts subject to validation of the account details with the depositories concerned.
Note: All capitalized terms used and not defined herein shall have the respective meanings assigned to them in the prospectus.
INVESTORS PLEASE NOTE
The details of Allotment made would be hosted on the website of Registrar to the Issue, Link Intlme India Private Limited at Website: www.linkintime.co.ln
All future correspondence in this regard may kindly be addressed to the Registrar to the Issue quoting full name of the First/ Sole applicant, Serial number of the Bid-Cum-Application Form, number of shares bid for, name of the Member of the Syndicate and Place where the bid was submitted and payment details at the address given below:
Link Intlme India Private Limited
THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET
PRICE OFTHE EQUITY SHARE ON LISTING OR
The Equity Shares have not been and will not be registered under the U.S. Securities Act of 1933, as amended ("Securities Act"), or any U.S state securities laws and may not be offered or sold within the United States, except pursuant to an exemption from or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws. Accordingly, the Equity Shares are being offered and sold only outside the United States in compliance with Regulation S and the applicable laws of the jurisdiction where those offers and sales occur. There will be no offering of the Equity Shares In the United States.